Leishmaniasis is a clinically heterogeneous syndrome caused by intracellular protozoan
parasites of the genus Leishmania. The clinical spectrum of leishmaniasis encompasses …

Leishmaniasis is a neglected tropical disease caused by a protozoan species of the genus
Leishmania affecting mostly the developing countries. The disease with current mortality rate …

Topical drug delivery is preferable route over systemic delivery in case of Cutaneous
leishmaniasis (CL). Among the available agents, amphotericin B (AmB) and pentamidine …

Visceral leishmaniasis (VL), caused by the Leishmania donovani complex, is a vector-borne
systemic disease, with a worldwide distribution causing high morbidity and mortality in the …

Leishmaniasis is a vector-borne protozoan infection whose clinical spectrum ranges from
asymptomatic infection to fatal visceral leishmaniasis. Over the last decades, an increase in …

Leishmaniasis is one of the six major tropical diseases targeted by the World Health
Organization. It is a life-threatening disease of medical, social and economic importance in …

Targeted and localized drug delivery via dermal route is an effective approach to improve
drug delivery and reduce drugs associated toxicities, most particularly treating cutaneous …

Co-infection among leishmaniasis and other infectious diseases is common among natural
populations especially in the endemic areas of the disease. It depends on the environmental …

Visceral leishmaniasis (VL) is an important parasitic disease which is endemic in different
parts of Iran; and domestic and wild canines are principal reservoir hosts of the disease. The …

Amplification of internal transcript spacer 1 of ribosomal RNA (ITS1‐RNA) gene followed by
RFLP analysis and sequencing was used to identify the causing agents of cutaneous and …